YORKVILLE ADVISORS GLOBAL LP
Q2 2025 Form 13-F

MOUNTAINSIDE, DELAWARE
CIK 0001838613 · CRD 165390 · SEC-registered investment adviser
$346.0M Reported Value Total

YORKVILLE ADVISORS GLOBAL, LP reports 5 total accounts under management (AUM). There are 5 discretionary accounts valued at $631,927,831, and 0 non-discretionary accounts.

Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered Discretionary Manager
Private funds (Form ADV)
6 funds · $912.7M gross asset value
Hedge Fund: $902.0M · Private Equity Fund: $10.7M
Source: Form ADV filed 2026-05-21
Reported value
$346.0M
Quarter over quarter
0.0%
Holdings
20
Top-10 concentration
99.4%

Key People

Form ADV owners & control persons
Mark Anthony Angelo
PRESIDENT/MANAGING PARTNER/LIMITED PARTNER
Matthew Jacob Beckman
MANAGING PARTNER/LIMITED PARTNER
David Nmn Gonzalez
GENERAL COUNSEL/CHIEF COMPLIANCE OFFICER

Filing Navigation

13F Metrics

Loading 13F Metrics

Q2 2025 13F record

Q2 2025 13F filing summary

Q2 2025 Form 13F portfolio summary
Period of report June 30, 2025
Filed November 21, 2025
Form 13F-HR
Reported value $346.0M
Positions 20
Change in reported value First reported quarter
Top-10 concentration 99.4%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q2 2026 13F
Filed Aug 6, 2026
34 $86.2M
Q1 2026 13F
Filed May 13, 2026
38 $154.6M
Q4 2025 13F
Filed Feb 10, 2026
28 $158.7M
Q3 2025 13F
Filed Nov 18, 2025
30 $258.8M
Q2 2025 13F
Filed Nov 21, 2025
20 $346.0M

Top 20 holdings · Q2 2025

Largest Q2 2025 13F positions by reported value
# Holding Reported value % of portfolio
1 DJT Trump Media & Technology Group $175.0M 50.58%
2 SQNS Sequans Communications SA $150.3M 43.45%
3 SGMOQ Sangamo Therapeutics Inc $11.9M 3.44%
4 MRNO Murano Global Investments PLC $2.7M 0.77%
5 LAZRQ Luminar Technologies, Inc $1.2M 0.34%
6 BURU Nuburu Inc $931.8K 0.27%
7 FBLG FibroBiologics Inc $525.2K 0.15%
8 ILLR Triller Group Inc $447.0K 0.13%
9 APUS Apimeds Pharmaceutical US Inc $440.0K 0.13%
10 COEP Coeptis Therapeutic Holdings Inc $411.2K 0.12%
11 CELU Celularity Inc $392.0K 0.11%
12 NITO N2OFF Inc $346.3K 0.1%
13 MSPR MSP Recovery, Inc $319.7K 0.09%
14 MDCX Medicus Pharma Ltd $316.5K 0.09%
15 EVTV Envirotech Vehicles, Inc. $223.8K 0.06%
16 RZLV C Rezolve AI PLC $182.0K 0.05%
17 NRSN Neurosense Therapeutics Ltd $113.4K 0.03%
18 SCNI Scinai Immunotherapeutics Ltd $95.8K 0.03%
19 DJT P Trump Media & Technology Group $49.8K 0.01%
20 FRSX Foresight Autonomous Holdings Ltd $46.5K 0.01%

Values as reported on the Q2 2025 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings